Legal & General Group PLC Emergent Bio Solutions Inc. Transaction History

Legal & General Group PLC

  • $390 Billion
  • Q2 2025

A detailed history of Legal & General Group PLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 4,913 shares of EBS stock, worth $63,082. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,913
Holding current value
$63,082
% of portfolio
0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
BUY
$4.26 - $6.94 $20,929 - $34,096
4,913 New
4,913 $31,000
Q1 2024

May 29, 2025
BUY
$1.5 - $3.41 $6,568 - $14,932
4,379 New
4,379 $11,000
Q1 2024

May 14, 2024
SELL
$1.5 - $3.41 $3,346 - $7,607
-2,231 Reduced 33.75%
4,379 $11,000
Q4 2023

May 29, 2025
BUY
$1.82 - $3.16 $12,030 - $20,887
6,610 New
6,610 $15,000
Q4 2023

Feb 15, 2024
SELL
$1.82 - $3.16 $43,012 - $74,680
-23,633 Reduced 78.14%
6,610 $15,000
Q3 2023

Nov 14, 2023
SELL
$3.17 - $7.91 $758,888 - $1.89 Million
-239,397 Reduced 88.78%
30,243 $102,000
Q2 2023

Aug 14, 2023
SELL
$7.35 - $13.21 $116,504 - $209,391
-15,851 Reduced 5.55%
269,640 $1.98 Million
Q1 2023

May 15, 2023
BUY
$7.79 - $16.29 $700,687 - $1.47 Million
89,947 Added 46.0%
285,491 $2.96 Million
Q4 2022

Feb 14, 2023
BUY
$11.0 - $21.45 $166,331 - $324,345
15,121 Added 8.38%
195,544 $2.31 Million
Q3 2022

Nov 14, 2022
BUY
$20.09 - $35.8 $483,365 - $861,347
24,060 Added 15.39%
180,423 $3.79 Million
Q2 2022

Aug 22, 2022
SELL
$27.42 - $43.63 $1.51 Million - $2.41 Million
-55,165 Reduced 26.08%
156,363 $4.85 Million
Q1 2022

May 16, 2022
BUY
$36.48 - $52.22 $157,630 - $225,642
4,321 Added 2.09%
211,528 $8.69 Million
Q4 2021

Feb 14, 2022
BUY
$33.11 - $55.01 $2.25 Million - $3.73 Million
67,883 Added 48.72%
207,207 $9.01 Million
Q3 2021

Nov 15, 2021
BUY
$50.07 - $66.05 $1.15 Million - $1.51 Million
22,919 Added 19.69%
139,324 $6.98 Million
Q2 2021

Aug 12, 2021
BUY
$56.61 - $80.46 $259,556 - $368,909
4,585 Added 4.1%
116,405 $7.33 Million
Q1 2021

May 17, 2021
BUY
$86.23 - $125.19 $1.07 Million - $1.55 Million
12,367 Added 12.44%
111,820 $10.4 Million
Q4 2020

Feb 12, 2021
SELL
$79.17 - $111.47 $119,388 - $168,096
-1,508 Reduced 1.49%
99,453 $8.91 Million
Q3 2020

Nov 13, 2020
SELL
$81.91 - $134.94 $6.71 Million - $11.1 Million
-81,931 Reduced 44.8%
100,961 $10.4 Million
Q2 2020

Aug 14, 2020
BUY
$54.33 - $89.52 $2.5 Million - $4.12 Million
46,044 Added 33.65%
182,892 $14.5 Million
Q1 2020

May 14, 2020
BUY
$49.34 - $68.76 $18,403 - $25,647
373 Added 0.27%
136,848 $7.9 Million
Q4 2019

Feb 13, 2020
BUY
$51.21 - $59.06 $616,619 - $711,141
12,041 Added 9.68%
136,475 $7.36 Million
Q3 2019

Nov 13, 2019
SELL
$40.6 - $57.2 $8,810 - $12,412
-217 Reduced 0.17%
124,434 $6.51 Million
Q2 2019

Aug 14, 2019
BUY
$39.92 - $53.86 $16,447 - $22,190
412 Added 0.33%
124,651 $6.02 Million
Q1 2019

May 15, 2019
BUY
$48.23 - $66.16 $906,868 - $1.24 Million
18,803 Added 17.83%
124,239 $6.28 Million
Q4 2018

Feb 15, 2019
BUY
$55.63 - $73.24 $94,404 - $124,288
1,697 Added 1.64%
105,436 $6.23 Million
Q3 2018

Nov 20, 2018
BUY
$52.05 - $66.51 $1.2 Million - $1.53 Million
22,982 Added 28.46%
103,739 $6.83 Million
Q2 2018

Aug 10, 2018
BUY
$48.33 - $55.64 $305,928 - $352,201
6,330 Added 8.5%
80,757 $4.09 Million
Q1 2018

May 17, 2018
BUY
$44.44 - $54.39 $134,253 - $164,312
3,021 Added 4.23%
74,427 $3.9 Million
Q4 2017

Feb 13, 2018
BUY
$37.77 - $47.75 $2.7 Million - $3.41 Million
71,406
71,406 $3.32 Million

Others Institutions Holding EBS

# of Institutions
192
Shares Held
39.4M
Call Options Held
299K
Put Options Held
157K
View Full List

About Emergent BioSolutions Inc.

EBS Quotes by TradingView
  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $640M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email